Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, UK.
FEBS Lett. 2018 Sep;592(18):3152-3162. doi: 10.1002/1873-3468.13212. Epub 2018 Aug 24.
Ly6/urokinase-type plasminogen activator receptor (uPAR) (LU) domain containing 6 (LYPD6) is a Wnt signaling enhancer that promotes phosphorylation of the Wnt coreceptor low density lipoprotein receptor-related protein 6 (LRP6). It also binds the nicotinic acetylcholine receptor (nAChR). We report here the 1.25 Å resolution structure of the LYPD6 extracellular LU domain and map its interaction with LRP6 by mutagenesis and surface plasmon resonance. The LYPD6 structure reveals a 'trifingered protein domain' fold with the middle fingertip bearing an 'NxI' motif, a tripeptide motif associated with LRP5/6 binding by Wnt inhibitors. Of the Ly6 protein family members, only LYPD6 has an NxI motif. Since mutations in the LYPD6 NxI motif abolish or severely reduce interaction with LRP6, our results indicate its key role in the interaction of LYPD6 with LRP6.
LY6/尿激酶型纤溶酶原激活物受体 (uPAR) (LU) 结构域包含 6 (LYPD6) 是一种 Wnt 信号增强剂,可促进 Wnt 核心受体低密度脂蛋白受体相关蛋白 6 (LRP6) 的磷酸化。它还与烟碱型乙酰胆碱受体 (nAChR) 结合。我们在此报告 LYPD6 细胞外 LU 结构域的 1.25Å 分辨率结构,并通过突变和表面等离子体共振映射其与 LRP6 的相互作用。LYPD6 结构揭示了一种“三指蛋白结构域”折叠,其中间指尖带有“NxI”基序,这是一种三肽基序,与 Wnt 抑制剂结合 LRP5/6 有关。在 Ly6 蛋白家族成员中,只有 LYPD6 具有 NxI 基序。由于 LYPD6 NxI 基序中的突变会使 LRP6 的相互作用完全丧失或严重降低,因此我们的结果表明它在 LYPD6 与 LRP6 的相互作用中起关键作用。